Sign In
to Vote &
Create Storyboards.
 

Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity

New England Journal of Medicine - 29 Sep 2026 06:00
New England Journal of Medicine, Volume 395, Issue 18, Page 1781-1793, November 5, 2026.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard